Evidence map›Paper›PMID 42222839›Full record

ReviewFrontiers in artificial intelligence2026

Review of deep learning models for Alzheimer's disease detection: MRI-centric approaches and multimodal extensions.

Rajaa Daami Resen, Laith Sabah Alzubaidi, Haider A Alwzwazy, Manuel I Capel

Abstract readReview
In one paragraph

Review in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rajaa Daami ResenDepartment of Computer Languages and Systems, University of Granada, Granada, Spain.
Laith Sabah AlzubaidiSchool of Mechanical, Medical, and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia.
Haider A AlwzwazySchool of Mechanical, Medical, and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia.
Manuel I CapelDepartment of Computer Languages and Systems, University of Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD) is a leading cause of dementia worldwide, and an early, reliable diagnosis is critical for timely intervention. Structural magnetic resonance imaging (MRI), coupled with deep learning (DL), has emerged as a promising non-invasive approach for automated diagnosis. This review evaluates DL models applied to MRI for AD detection, while also considering multimodal extensions (PET, fMRI, DTI, CSF, and cognitive data) that augment MRI-based pipelines. Methods: Following PRISMA guidelines, a comprehensive search of six databases (2010-June 2025) identified 70 peer-reviewed studies, with many of them integrating multimodals as well. Data on model architectures, datasets, pre-processing, validation protocols, and reported performance outcomes were extracted and synthesised. Results: Most studies have employed 2D or 3D convolutional neural networks; however, recent work has also explored ensembles, vision transformers, graph neural networks, and generative models. ADNI was the primary dataset, in addition to OASIS, AIBL, UK Biobank, and other cohorts that were also utilised. Binary classification tasks distinguishing clinically diagnosed Alzheimer's disease (AD) patients from cognitively normal (CN) controls consistently reported high performance (>90% accuracy, AUC ≥ 0.95). In contrast, more clinically challenging tasks, such as multiclass classification across disease stages (CN, MCI, AD) and prediction of MCI-to-AD conversion, yielded substantially lower accuracy (approximately 70-85%). Reported near-perfect results (>99%) were often confined to single-site datasets lacking external validation, raising concerns of overfitting and reproducibility. Discussion: Few studies have incorporated differential diagnosis of dementia, advanced harmonisation across scanners, or open-source pipelines. Promising advances include transfer learning, multimodal integration, harmonisation methods (such as ComBat, GANs, diffusion), and explainable AI techniques. Overall, DL shows strong potential for MRI-based AD detection, with multimodal inputs further improving performance.

Indexed as

Alzheimer’s diseaseclinical translationCNNdeep learningMRIsystematic review

Identifiers

PMID42222839
PMCPMC13219310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.